文献速递主动脉疾病

新一代开窗/分支支架治疗主动脉弓动脉瘤的解剖分析与可行性研究

Anatomical Analysis and Feasibility Study of Next-Generation Fenestrated or Branched Stent-Grafts for the Treatment of Arch Aneurysms.
PubMed 文献 · J Endovasc Ther · 2020-06-26

本研究回顾性分析213例主动脉弓动脉瘤患者,基于三维工作站中心线技术评估四种新一代分支或开窗支架(Zenith A-branch、TAG TBE、Relay Plus DB、Najuta)按说明书(IFU)的解剖可行性。结果显示仅5.2%至40.8%的患者符合任一支架的IFU,且近半数患者封堵区存在>50%周径的血栓/钙化,但目前缺乏标准化评估方法。

要点

  • 仅5.2%~40.8%的弓部动脉瘤患者解剖上适合任一新一代分支/开窗支架。
  • TAG TBE的解剖适合率最高(40.8%),Zenith A-branch最低(5.2%)。
  • 近半数患者封堵区存在>50%周径血栓/钙化,但无标准化定义。

核心结论

  • 仅5%至41%的主动脉弓动脉瘤患者解剖上适合使用任一种新一代分支或开窗支架行TEVAR。
  • 未来IFU需建立明确的血栓/钙化负荷评估方法。

研究设计与样本

  • 回顾性分析2007至2017年两家日本医院213例(平均年龄75.0±7.1岁,179例男性)接受全弓置换或0/1区TEVAR的弓部动脉瘤患者。
  • 使用三维工作站中心线技术进行解剖分析,基于IFU评估四种支架的解剖可行性。

主要发现

  • 窦管交界至头臂动脉平均长度114.9±15.9 mm,头臂动脉至左颈总动脉平均长度12.8±5.6 mm。
  • 窦管交界和头臂动脉处平均主动脉直径分别为31.3±3.4 mm和34.1±5.3 mm。
  • Zenith A-branch的IFU符合率为5.2%,TAG TBE为40.8%,Relay Plus DB为24.9%,Najuta为13.6%。
  • 近半数患者封堵区存在>50%周径的血栓/钙化,但目前无标准化定义或评估方法。

关键数值与推荐

  • Zenith A-branch解剖适合率5.2%。
  • TAG TBE解剖适合率40.8%。
  • Relay Plus DB解剖适合率24.9%。
  • Najuta解剖适合率13.6%。

临床怎么用

  • 弓部动脉瘤患者术前应基于IFU评估解剖适合性,选择合适的分支或开窗支架。
  • 封堵区血栓/钙化负荷影响支架选择,但目前评估方法不统一,需谨慎判断。

局限性

  • 回顾性研究,样本来自两家日本医院,外推性有限。
  • 血栓/钙化负荷无标准化定义和评估方法,影响可行性判断的一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To analyze the anatomical characteristics of arch aneurysms and evaluate the anatomical feasibility of 4 next-generation stent-grafts with either branched or fenestrated configurations. Materials and Methods: A retrospective analysis was conducted of 213 patients (mean age 75.0±7.1 years; 179 men) with arch aneurysms treated using total arch replacement or zone 0 or 1 thoracic endovascular aortic repair (TEVAR) from 2007 to 2017 at 2 Japanese hospitals. Anatomical analyses were performed using the centerline of flow technique on a 3-dimensional workstation. The anatomical feasibility of the Zenith A-branch, TAG Thoracic Branch Endoprosthesis (TBE), Terumo Aortic Relay Plus Double Branched (DB), and fenestrated Najuta stent-grafts were evaluated based on the instructions for use (IFU). Results: The mean lengths from the sinotubular junction (STJ) to the innominate artery (IA) and from the IA to the left common carotid artery were 114.9±15.9 and 12.8±5.6 mm, respectively. The mean aortic diameters at the STJ and IA were 31.3±3.4 and 34.1±5.3 mm, respectively. In terms of feasibility, 5.2% of patients were within the Zenith A-branch IFU, 40.8% for the TAG TBE, 24.9% for the Relay Plus DB, and 13.6% for the Najuta. Significant (>50% circumference) thrombus/calcification at the sealing zone affected nearly half of the patients, but there is currently no standardized definition or evaluation method for "significant" thrombus/calcification. Conclusion: Only 5% to 41% of arch aneurysm patients are anatomically suitable for TEVAR using any one of the next-generation branched or fenestrated stent-grafts. Furthermore, a definitive method of evaluating the thrombus/calcification burden needs to be established in future IFU.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Fujimura N, Ichihashi S, Motoki M, et al. Anatomical Analysis and Feasibility Study of Next-Generation Fenestrated or Branched Stent-Grafts for the Treatment of Arch Aneurysms. J Endovasc Ther. 2020. PMID: 32589119. doi:10.1177/1526602820938058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。